What is Invision Diagnostics?
Invision Diagnostics operates at the intersection of mobile health and oncology, providing essential 3D mammography services across the Carolinas. By deploying advanced imaging technology to corporate sites and community hubs, the company effectively dismantles traditional barriers to preventative care. This decentralized approach to breast cancer screening not only improves early detection rates but also optimizes the patient experience by integrating health services into daily routines. As a leader in the mobile diagnostic sector, Invision Diagnostics leverages a robust logistics network to ensure that high-quality medical imaging is accessible, reliable, and patient-centric.
How much funding has Invision Diagnostics raised?
Invision Diagnostics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Invision Diagnostics
PPP
Public-Private Partnership
What's next for Invision Diagnostics?
With this latest infusion of capital, Invision Diagnostics is poised to accelerate its market penetration and technological integration. The strategic roadmap likely involves expanding the fleet of mobile screening units to reach underserved rural populations and enhancing the digital backend for seamless integration with regional healthcare providers. As the company transitions through this late-stage growth phase, the focus will shift toward operational efficiency and the potential for geographic diversification. By maintaining a high standard of diagnostic accuracy while scaling its footprint, Invision Diagnostics is set to redefine the delivery of preventative women's health services in the Southeast.
See full Invision Diagnostics company page
